Apolipoprotein E polymorphism, age and coronary heart disease

Ageing Res Rev. 2007 Aug;6(2):94-108. doi: 10.1016/j.arr.2006.11.001. Epub 2006 Dec 20.

Abstract

Plasma concentrations of lipids, lipoproteins, and apolipoproteins (apo) are established risk factors for coronary heart disease (CHD). The knowledge of lipid profile may predict the potential victims of cardiovascular disease before its initiation and progression and offer the opportunity for primary prevention. The most common apo E polymorphism has been found to influence blood lipid concentrations and its correlation with CHD has been extensively investigated in the last decade. At younger ages, death from CHD is influenced by genetic factors, while the genetic effect decreases at older ages where environmental factors may play a more prominent role. If apo E polymorphism is an important genetic factor in the pathogenesis of atherosclerosis, it could affect the age of CHD onset. This review analyses the influence of apo E polymorphism on blood lipids and CHD in respect to age.

Publication types

  • Review

MeSH terms

  • Aging / genetics*
  • Apolipoproteins E / genetics*
  • Apolipoproteins E / physiology
  • Coronary Artery Disease / genetics
  • Coronary Artery Disease / physiopathology
  • Coronary Disease / genetics*
  • Coronary Disease / physiopathology
  • Genotype
  • Humans
  • Lipid Metabolism / genetics
  • Lipid Metabolism / physiology
  • Lipids / blood
  • Polymorphism, Genetic / genetics
  • Risk Factors

Substances

  • Apolipoproteins E
  • Lipids